Navigation Links
Biotech cotton 8: Bugs 0

Biotech cotton has beaten back pink bollworm eight years running, reports a team of scientists from The University of Arizona in Tucson.

The surprising finding is good news for the environment. Arizona farmers who plant the biotech cotton known as Bt cotton use substantially less chemical insecticides than in the past.

Insect pests sometimes evolve resistance to such chemicals in just a few years, a fate that was predicted for biotech crops genetically altered to produce Bt toxin, a naturally occurring insecticide.

"This is the most complete study to date for monitoring resistance to Bt crops," said team leader Bruce E. Tabashnik, the head of UA's department of entomology, a member of UA's BIO5 Institute and an expert in insect resistance to insecticides.

"We found no net increase in insect resistance to Bt. If anything, resistance decreased. This is the opposite of what experts predicted when these crops were first commercialized." He added, "I'm definitely surprised."

Tabashnik, Timothy J. Dennehy, a UA Distinguished University Outreach Professor of Entomology and extension specialist and a member of BIO5, and Yves Carriere, UA associate professor of entomology, will publish their research in an upcoming issue of the Proceedings of the National Academy of Sciences.

Bt cotton has been planted in Arizona since 1996. Now more than half of the state's 256,000 acres of cotton fields are planted with the biotech plants. Without the protection provided by Bt cotton, some fields can have 100 percent of plants infested with pink bollworm caterpillars, which live inside the cotton boll, destroying the crop.

Dennehy said, "In an extreme infestation, you can have every single boll in the field infected." The caterpillars eat the seeds and damage the developing cotton fibers.

In contrast, when the caterpillars eat Bt cotton, they die.

Before the use of Bt cotton became widespread, pink bollworm was one of t
'"/>

Source:University of Arizona


Page: 1 2 3

Related biology news :

1. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
2. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
3. Biotechnologys newest chemical tool
4. Biotechnologys newest chemical tool
5. Open Source Biotechnology alliance for international agriculture
6. Biotech cotton provides same yield with fewer pesticides
7. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
8. Bt cotton in China fails to reap profit after seven years
9. Scientists seek useful traits in wild cottons
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech cotton Bugs

(Date:6/19/2013)... June 19, 2013 A study published in the ... the first report of an oral probiotic supplement significantly ... , The lead author on the study, Mitchell ... Presentation Prize from the New York Academy of Sciences ... week,s Probiotics, Prebiotics, and the Host Microbiome: The ...
(Date:6/19/2013)... the Marine Biological Laboratory (MBL), Woods Hole, Massachusetts, ... by the American Society for Microbiology (ASM). ... and the scientists who worked there that have ... microbiology. A ceremony unveiling the plaque that ... June 22, 2013, at 4:30 pm in the ...
(Date:6/19/2013)... A team of researchers at the University of ... outer coating of HIV, that could be potential ... avoid generating resistance. These new agents are quite ... The research was published in the June 2013 ... Chemotherapy . , The first of many probable ...
Breaking Biology News(10 mins):Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels 2Microbial diversity course designated as a 'Milestones in Microbiology' site 2HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... under scrutiny lately due to adverse cardiovascular side-effects stemming ... models, researchers reveal another adverse effect of Celecoxib; this ... independent of the COX-2 enzyme. Satpal Singh ... rate of Drosophila, a good model for human cardiac ...
... friends used to think he was eccentric, crawling like ... Pennsylvania, hauling dental tools and a jack hammer. ... gotten over it, and are congratulating him on receiving ... Society, presented at the Geological Society of Americas recent ...
... of medical and scientific books and journals, was ... content is immediately available on www.springerlink.com ... and more than 22,000 eBooks. Beginning with the ... purchase Humana Press journals through Springer. All issues ...
Cached Biology News:Academy volunteer wins national paleontology award 2Humana Press journals now available on SpringerLink 2
(Date:6/19/2013)... Raleigh, NC (PRWEB) June 19, 2013 ... and eclinical commerce network for clinical trials, today ... technology at DIA 2013 (booth #2000) in Boston, ... is the industry’s first and only fully configurable, ... technology, ClinPay®, the flagship module within Clinverse’s eClinical ...
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
(Date:6/19/2013)... 2013 Today DuPont Executive Vice President ... become leaders in the greatest challenge facing our time ... 2050. Borel spoke at the International Food ... about urgent need for students to contribute their time ... sustainable and reached in collaboration with others. , “Food ...
(Date:6/19/2013)... Bloomington, Indiana (PRWEB) June 19, 2013 ... Valentine joined the speaking faculty at 2013’s BioLogistics ... , The conference, coordinated by Cold Chain IQ ... surrounding biologics. This “complexity” is, in part, attributed ... medicine. , “Implicit within these trends is ...
Breaking Biology Technology:Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2
... Chindex International,Inc. (Nasdaq: CHDX ), an independent ... products in the People,s,Republic of China, today announced ... ended March 31, 2008., For the 2008 ... $130.1,million, an increase of 23% over the prior ...
... Takes Prominent Position and ... WEST SENECA, N.Y., June 11 Palladian Muscular Skeletal,Health ... a high-profile presence at a leading healthcare event -- ... June,18 to Friday, June 20, 2008., "We have ...
... Rosetta Genomics has Signed a Binding Term Sheet to Acquire Parkway ... ... Significantly Streamline the Development and Commercialization of Rosetta Genomics, microRNA-based ... Needs to Market and Sell its microRNA-based Tests in the U.S. and ...
Cached Biology Technology:Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 2Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 3Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 4Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 5Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 6Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 7Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 8Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 9Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results 10Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June 2Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 2Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 3Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 4Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 5Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 6
... Rabbit polyclonal to Taura ... Abpromise for all tested ... Synthetic peptide: VTNSEGSTIL MNDIPITNQN ... ATEFNQ, corresponding to N terminal ...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
... Immunogen: KLH-conjugated, synthetic peptide ... which [ Ac K] corresponds to acetyl ... Accession Number: NM_003493 ... Quality Assurance: Routinely ...
Blank Calibration Particles, 3.0-3.4 mu m 5 ml...
Biology Products: